等待開盤 11-03 09:30:00 美东时间
-0.030
-0.29%
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
10-20 10:03
Oppenheimer analyst Ittai Kidron maintains Backblaze (NASDAQ:BLZE) with a Outperform and raises the price target from $10 to $11.
10-18 01:52
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
Backblaze shares are trading higher after the company reported better-than-expe...
08-07 22:33
Backblaze (NASDAQ:BLZE) sees Q3 sales of $36.700 million-$37.100 million vs $36.588 million analyst estimate.
08-07 19:04
Backblaze (NASDAQ:BLZE) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.18) by 105.62 percent. This is a 109.09 percent increase over losses of $(0.11) per share from the
08-07 19:04
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
多家机构首予Amrize买入评级,目标价53~62美元;HC Wainwright & Co.上调内克塔治疗目标价至120美元,维持"买入"评级>>
06-25 08:39
JMP Securities analyst Rustam Kanga initiates coverage on Backblaze (NASDAQ:BLZE) with a Market Outperform rating and announces Price Target of $7.
06-24 21:39
Backblaze (NASDAQ:BLZE) closes its senior secured revolving credit facility in an aggregate principal amount of up to $20M, of which an aggregate amount of up to $3M will be available through a letter...
06-05 23:27